Relation Therapeutics vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 34)
Relation Therapeutics logo

Relation Therapeutics

EmergingLife Sciences & BioTech

AI-Driven Drug Discovery

Relation Therapeutics uses its Lab-in-the-Loop AI platform to discover novel drug targets; secured a $1.7B multi-program Novartis collaboration and a $200M+ GSK partnership; raised $26M additional funding from NVIDIA Ventures in December 2025.

AI VisibilityBeta
Overall Score
D34
Category Rank
#197 of 198
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
28
Gemini
39

About

Relation Therapeutics is a UK-based clinical-stage biotechnology company that integrates artificial intelligence with experimental biology to discover novel therapeutic targets for diseases with significant unmet medical need. Its proprietary Lab-in-the-Loop platform combines machine learning with patient-derived single-cell multi-omics data, functional assays, and human genetics to identify causal genes and validate novel drug targets — moving beyond correlative genomics to experimental confirmation. The company''s initial therapeutic focus is osteoporosis, with additional programs in immunology, metabolic disease, and fibrosis.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

34
Overall Score
74
#197
Category Rank
#11
71
AI Consensus
68
stable
Trend
stable
39
ChatGPT
71
28
Perplexity
68
39
Gemini
80
38
Claude
77
38
Grok
69

Key Details

Category
AI-Driven Drug Discovery
AI-Enabled Precision Medicine
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.